Evidence map›Paper›PMID 34796674›Full record

ArticleInfluenza and other respiratory viruses2022

Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa.

Tendesayi Kufa, Waasila Jassat, Cheryl Cohen, Stefano Tempia, Maureen Masha, Nicole Wolter, Sibongile Walaza, Anne von Gottburg, Nelesh P Govender, Gillian Hunt and 17 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.Journal of the Pediatric Infectious Diseases Society · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.medRxiv : the preprint server for health sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Burden of SARS-CoV-2 and protection from symptomatic second infection in children.medRxiv : the preprint server for health sciences · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Tendesayi KufaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0002-9797-616X
Waasila JassatNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Cheryl CohenNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0003-0376-2302
Stefano TempiaSchool of Public Health, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0003-4395-347X
Maureen MashaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Nicole WolterNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Sibongile WalazaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0001-7588-2480
Anne von GottburgNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Nelesh P GovenderNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Gillian HuntNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Andronica Moipone ShonhiwaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Joy EbonwuNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Genevie NtshoeNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Wellington MarumaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.ORCID 0000-0003-3749-5572
Poncho BapelaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Nomathamsanqa NdhlovuNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Hlengani MathemaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Motshabi ModiseNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Liliwe ShupingNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Pinky N MananaNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
David MooreDepartment of Pediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa.
Ziyaad DangorDepartment of Pediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa.
Charl VerweyDepartment of Pediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa.
Shabir A MadhiSouth African Medical Research Council: Vaccines and Infectious Diseases Analytical Research Unit (VIDA), Faculty of Health Science Johannesburg, University of the Witwatersrand, Johannesburg, South Africa.
Haroon SaloojeeDepartment of Pediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa.
Heather J ZarDept of Paediatrics and Child Health, Red Cross Children's Hospital, and SA-MRC Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
Lucille BlumbergNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.

Funding

Medical Research Council MR/V028782/1National Department of Health, Republic of South Africa
6 · The paper itself

Abstract

introductionWe describe epidemiology and outcomes of confirmed SARS-CoV-2 infection and positive admissions among children <18 years in South Africa, an upper-middle income setting with high inequality.

methodsLaboratory and hospital COVID-19 surveillance data, 28 January - 19 September 2020 was used. Testing rates were calculated as number of tested for SARS-CoV-2 divided by population at risk; test positivity rates were calculated as positive tests divided by total number of tests. In-hospital case fatality ratio (CFR) was calculated based on hospitalized positive admissions with outcome data who died in-hospital and whose death was judged SARS-CoV-2 related by attending physician.

findings315 570 children aged <18 years were tested for SARS-CoV-2; representing 8.9% of all 3 548 738 tests and 1.6% of all children in the country. Of children tested, 46 137 (14.6%) were positive. Children made up 2.9% (n = 2007) of all SARS-CoV-2 positive admissions to sentinel hospitals. Among children, 47 died (2.6% case-fatality). In-hospital deaths were associated with male sex [adjusted odds ratio (aOR) 2.18 (95% confidence intervals [CI] 1.08-4.40)] vs female; age <1 year [aOR 4.11 (95% CI 1.08-15.54)], age 10-14 years [aOR 4.20 (95% CI1.07-16.44)], age 15-17 years [aOR 4.86 (95% 1.28-18.51)] vs age 1-4 years; admission to a public hospital [aOR 5.07(95% 2.01-12.76)] vs private hospital and ≥1 underlying conditions [aOR 12.09 (95% CI 4.19-34.89)] vs none.

conclusionsChildren with underlying conditions were at greater risk of severe SARS-CoV-2 outcomes. Children > 10 years, those in certain provinces and those with underlying conditions should be considered for increased testing and vaccination.

Indexed as

COVID-19AdolescentChildChild, PreschoolFemaleHospitalsHumansInfantMaleRisk FactorsSARS-CoV-2South AfricaadolescentschildrenCOVID-19incidencemortalitytesting rate

Identifiers

PMID34796674
PMCPMC9664941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.